ARAY / Accuray Incorporated - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

PROSPECTUS Accuray Incorporated 23,428,241 Shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-288998 PROSPECTUS Accuray Incorporated 23,428,241 Shares of Common Stock This prospectus covers the offer and resale by the selling stockholders (the “Selling Stockholders”) identified herein, from time to time in one or more offerings, of up to 23,428,241 shares of our common stock, par value $0.001 per share, which consist of (i) an aggregate

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 A

ACCURAY INCORPORATED INSIDER TRADING POLICY

EXHIBIT 19.1 ACCURAY INCORPORATED INSIDER TRADING POLICY A. POLICY OVERVIEW Accuray Incorporated (together with any subsidiaries, collectively the “Company”) has adopted this Insider Trading Policy (the “Policy”) to help you comply with the federal and state securities laws and regulations that govern trading in securities and to help the Company minimize its own legal and reputational risk. It is

Subsidiaries of the Registrant

Exhibit 21.1 Subsidiaries of the Registrant Name State or Jurisdiction of Organization Accuray International SARL Switzerland Accuray Europe SAS France Accuray UK, Ltd. United Kingdom Accuray Asia Ltd. Hong Kong Accuray Japan K.K. Japan Accuray Korea Limited Company Korea Accuray Spain, S.L.U. Spain Accuray Medical Equipment (India) Private Limited India Accuray Medical Equipment (Rus) LLC. Russia

ACKNOWLEDGEMENT

EXHIBIT 97.1 Accuray Incorporated COMPENSATION RECOVERY POLICY As adopted on November 9, 2023 Accuray Incorporated (the “Company”) is committed to strong corporate governance. As part of this commitment, the Company’s Board of Directors (the “Board”) has adopted this Compensation Recovery Policy (the “Policy”). The Policy is intended to further the Company’s pay-for-performance philosophy and to c

[Signature page follows.]

EXHIBIT 10.30 September 3, 2024 Sandeep Chalke c/o Accuray Incorporated 1240 Deming Way Madison, WI 53717-1954 Re: Letter Agreement for Interim CEO Role Dear Sandeep, Accuray Incorporated (the “Company”) is pleased to offer you this letter agreement (the “Letter”) memorializing certain terms and conditions relating to your continued employment with the Company as its interim Chief Executive Office

FINANCING AGREEMENT Dated as of June 6, 2025 by and among ACCURAY INCORPORATED, as the Administrative Borrower, EACH SUBSIDIARY OF THE PARENT LISTED AS A GUARANTOR ON THE SIGNATURE PAGES HERETO, as Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERE

Certain information in this exhibit has been omitted because they are both (i) not material and (ii) is the type that the company treats as private or confidential, and has been marked with “[***]” to indicate where omissions have been made.

FORM 8-K Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On August 19, 2025, Robert C. Kill, a Class I director of Accuray Incorporated (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fi

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance

Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wisconsin, August 13, 2025 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025. Key Fiscal Fourth Quarter Highlights • Net revenue was $127.5 million, a de

Q4’FY25 Earnings CallSupplemental Presentation August 13, 2025

Q4’FY25 Earnings Call Supplemental Presentation August 13, 2025 Forward-looking Statements This presentation is intended exclusively for investors.

FORM 8-K Item 2.02 Results of Operations and Financial Condition. Item 7.01 Regulation FD Disclosure. Item 9.01 Financial Statements and Exhibits.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fi

CALCULATION OF FILING FEE TABLE Form S-3 (Form Type) Accuray Incorporated (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-3 (Form Type) Accuray Incorporated (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common stock, $0.

As filed with the Securities and Exchange Commission on July 28, 2025

As filed with the Securities and Exchange Commission on July 28, 2025 Registration No.

GOVERNANCE AGREEMENT ACCURAY INCORPORATED TCW ASSET MANAGEMENT COMPANY LLC dated as of June 6, 2025 TABLE OF CONTENTS

Exhibit 10.2 GOVERNANCE AGREEMENT among ACCURAY INCORPORATED and TCW ASSET MANAGEMENT COMPANY LLC dated as of June 6, 2025 TABLE OF CONTENTS Page Article 1 Definitions Section 1.01. Defined Terms 3 Article 2 Governance Rights Section 2.01. Board Designation Rights 5 Section 2.02. Board Observer 6 Article 3 Term and Termination Section 3.01. Term and Termination 7 Section 3.02. Effect of Terminatio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-33301 (Commission File Number) 20-

ACCURAY INCORPORATED Common Stock Purchase Warrant

Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM U

ACCURAY INCORPORATED Common Stock Purchase Warrant

Exhibit 4.2 Final Form THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Exhibit 99.1 Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities MADISON, Wis., June 6, 2025 - Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing

ACCURAY INCORPORATED Common Stock Purchase Warrant

Exhibit 4.4 Final Form THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION

ACCURAY INCORPORATED Common Stock Purchase Warrant

Exhibit 4.3 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS. THESE SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM U

Exchange Agreement

Exhibit 10.1 Confidential Exchange Agreement [●], 2025 Accuray Incorporated 3.75% Convertible Senior Notes due 2026 The undersigned investor (the “Investor”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Investor holds contractual and investment authority (each, including the Investor if it is a party exchanging Notes (as defined below), an

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.) 1240 Deming Way Madison, Wisconsin 53717 (Address of principal

CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2024 TO DECEMBER 31, 2024

EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2024 TO DECEMBER 31, 2024 Background This Conflict Minerals Report (“Report”) of Accuray Incorporated (“Accuray”) for calendar year 2024 (the “Reporting Period”) has been prepared in accordance with Rule 13p-1 and Form SD under the Securities Exchange Act of 1934, as amended (together, the “Rule”

Executive Employment Agreement by and between Registrant and Leonel Peralta, dated February 3, 2025.

EXHIBIT 10.1 Page 1 of NUMPAGES 34 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of February 3, 2025 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Leonel Peralta (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, includ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORATED

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Exhibit 99.1 Accuray Reports Fiscal 2025 Third Quarter Financial Results MADISON, Wis, April 30, 2025 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025. Key Fiscal Third Quarter Highlights: • Total net revenue was $113.2 million, an increase of 12 percent year-over-year • Net loss was $1.3 million compared to a net loss of $6.3 millio

FORM 8-K Item 9.01 Financial Statements and Exhibits.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fil

Q3’FY25 Earnings CallSupplemental Presentation April 30, 2025

Q3’FY25 Earnings Call Supplemental Presentation April 30, 2025 Forward-looking Statements This presentation is intended exclusively for investors.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Executive Employment Agreement by and between Registrant and Suzanne Winter, dated February 3, 2025

EXHIBIT 10.2 Page 1 of NUMPAGES 34 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of February 3, 2025 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Suzanne Winter (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, includ

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Exhibit 99.1 Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance MADISON, Wis, February 5, 2025 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2024. Key Fiscal Q2 Highlights: • Strong second quarter and first half results; raising fiscal year 2025 guidance • Total net revenue was $116.2 million, an

Executive Employment Agreement by and between Registrant and Sandeep Chalke, dated February3, 2025

EXHIBIT 10.4 Page 1 of NUMPAGES 34 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of February 3, 2025 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Sandeep Chalke (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, includ

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 05, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

Executive Employment Agreement by and between Registrant and Ali Pervaiz, dated February 3, 2025

EXHIBIT 10.3 Page 1 of NUMPAGES 34 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of February 3, 2025 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Ali Pervaiz (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, including

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORA

Executive Employment Agreement by and between Registrant and Jesse Chew, dated February 3, 2025

EXHIBIT 10.5 Page 1 of NUMPAGES 34 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of February 3, 2025 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Jesse Chew (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, including

Separation Agreement and General Release by and between Registrant and Michael Hoge, dated January 6, 2025.

Exhibit 10.1 Page 1 of NUMPAGES 29 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (this “Agreement”) is hereby entered into by and between Michael Hoge, an individual (“Executive”), and Accuray Incorporated, a Delaware corporation, on behalf of itself and all of its subsidiaries (collectively, the “Company”). Recitals A. Executive has been employed by the Co

Q2’FY25 Earnings CallSupplemental Presentation February 5, 2025

Q2’FY25 Earnings Call Supplemental Presentation February 5, 2025 Forward-looking Statements This presentation is intended exclusively for investors.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2025 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Leonel Peralta to Join Accuray as Chief Operations Officer

EXHIBIT 99.1 Leonel Peralta to Join Accuray as Chief Operations Officer MADISON, Wis., January 21, 2025 – Accuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer, effective February 3, 2025. Mr. Peralta will be responsible for leading worldwide manufacturing operations including driving alignment of operation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024 ACCURAY INCORPOR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Accuray Incorporated (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(5) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par val

Form of Accuray Incorporated Stand-Alone Inducement Restricted Stock Unit Agreement

EXHIBIT 99.3 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT RESTRICTED STOCK UNIT AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Award. Otherwise, Participant will be deemed to have accepted the Award on the terms and conditions on which it is offered. NOTICE OF GRANT OF RESTRICTED STOCK UNIT AWARD

As filed with the Securities and Exchange Commission on November 26, 2024

As filed with the Securities and Exchange Commission on November 26, 2024 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan and forms of award agreements thereunder

EXHIBIT 10.1 ACCURAY INCORPORATED AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN 1. Purposes of the Plan. The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to provide additional incentive to Employees, Directors and Consultants, and • to promote the success of the Company’s business. The Plan permits the grant of Inc

Accuray Incorporated Amended and Restated 2007 Employee Stock Purchase Plan

EXHIBIT 10.2 AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN Accuray Incorporated hereby approves the Accuray Incorporated Amended and Restated 2007 Employee Stock Purchase Plan (the “Plan”), effective as of the Effective Date (as defined herein). 1. Purpose. The purposes of the Plan are as follows: (a) To assist employees of the Company and its Designated Subsidiaries (as defined below) in

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 06, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPOR

Accuray Reports Fiscal 2025 First Quarter Financial Results Strong Start to Fiscal Year, Raises 2025 Guidance

Exhibit 99.1 Accuray Reports Fiscal 2025 First Quarter Financial Results Strong Start to Fiscal Year, Raises 2025 Guidance MADISON, Wis, November 6, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2024. “We continue to make solid progress in the execution of our strategic growth agenda and performed better than expected in the f

Fourth Amendment to Credit Agreement among Registrant, as Borrower, the several banks and other financial institutions or entities party hereto, and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as administrative agent, issuing lender and swingline lender, dated as of September 12, 2024.

EXHIBIT 10.1 FOURTH AMENDMENT TO CREDIT AGREEMENT This Fourth Amendment to Credit Agreement (this “Amendment”) dated and effective as of September 11, 2024 (the “Fourth Amendment Effective Date”) by and among ACCURAY INCORPORATED, a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto (the “Lenders”) and SILICON VALLEY BANK, a division

Q1’FY25 Earnings CallSupplemental Presentation November 6, 2024

Q1’FY25 Earnings Call Supplemental Presentation November 6, 2024 Forward-looking Statements This presentation is intended exclusively for investors.

Accuray Appoints Michael Murphy as VP, Corporate Controller

EXHIBIT 99.1 Accuray Appoints Michael Murphy as VP, Corporate Controller MADISON, Wis., October 21, 2024 – Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller. Mr. Murphy will be responsible for leading the global accounting function including corporate tax, regulatory reporting, accounting policies, and risk m

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2024 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

EXHIBIT 99.1 Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence MADISON, Wis., October 15, 2024 - Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke, who has served as interim CEO du

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2024 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )         Filed by the Registrant ☒     Filed by a Party other than the Registrant   ☐         Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission On

ACCURAY INCORPORATED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )         Filed by the Registrant ☒     Filed by a Party other than the Registrant   ☐         Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by

List of subsidiaries.

Exhibit 21.1 Subsidiaries of the Registrant Name State or Jurisdiction of Organization Accuray International SARL Switzerland Accuray Europe SAS France Accuray UK, Ltd. United Kingdom Accuray Asia Ltd. Hong Kong Accuray Japan K.K. Japan Accuray Korea Limited Company Korea Accuray Spain, S.L.U. Spain Accuray Medical Equipment (India) Private Limited India Accuray Medical Equipment (Rus) LLC. Russia

Compensation Recovery Policy

EXHIBIT 97.1 Accuray Incorporated COMPENSATION RECOVERY POLICY As adopted on November 9, 2023 Accuray Incorporated (the “Company”) is committed to strong corporate governance. As part of this commitment, the Company’s Board of Directors (the “Board”) has adopted this Compensation Recovery Policy (the “Policy”). The Policy is intended to further the Company’s pay-for-performance philosophy and to c

Insider Trading Policy

EXHIBIT 19.1 ACCURAY INCORPORATED INSIDER TRADING POLICY A. POLICY OVERVIEW Accuray Incorporated (together with any subsidiaries, collectively the “Company”) has adopted this Insider Trading Policy (the “Policy”) to help you comply with the federal and state securities laws and regulations that govern trading in securities and to help the Company minimize its own legal and reputational risk. It is

Second Amendment to Credit Agreement among Registrant, as the Borrower, the several banks and other financial institutions or entities party hereto, and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as administrative agent, issuing lender and swingline lender, dated as of November 20, 2023.

EXHIBIT 10.32 SECOND AMENDMENT TO CREDIT AGREEMENT This Second Amendment to Credit Agreement (this “Amendment”) dated and effective as of November 20, 2023 (the “Second Amendment Effective Date”) by and among ACCURAY INCORPORATED, a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto (the “Lenders”) and SILICON VALLEY BANK, a division

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One):  ☒Form 10-K  ☐Form 20-F  ☐Form 11-K  ☐Form 10-Q ☐Form 10-D  ☐Form N-CEN  ☐Form N-CSR For Period Ended: June 30, 2024 ☐Transition Report on Form 10-K ☐Transition Report on Form 20-F ☐Transition Report on Form 11-K ☐Transition Report on Form 10-Q For the Transition Period Ende

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2024 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission Fil

ARAY / Accuray Incorporated / Archon Capital Management LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Exhibit 99.1 Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence MADISON, Wis., September 3, 2024 — Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2024 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File N

Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. 2 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including

Q4’FY24 Earnings Call Supplemental Presentation August 14, 2024 Exhibit 99.2 Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. 2 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of histo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fi

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results 14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance

Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results 14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wisconsin, August 14, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024. Fourth Quarter Fiscal 2024 Summary • Net revenue of $134.3 million, an increase of 13

Conflict Minerals Report of Accuray Incorporated

EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2023 TO DECEMBER 31, 2023 Background This Conflict Minerals Report (“Report”) of Accuray Incorporated (“Accuray”) for calendar year 2023 (the “Reporting Period”) has been prepared in accordance with Rule 13p-1 and Form SD under the Securities Exchange Act of 1934, as amended (together, the “Rule”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.) 1240 Deming Way Madison, Wisconsin 53717 (Address of principal

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Numbe

Third Amendment to Credit Agreement among Registrant, as the Borrower, the several banks and other financial institutions or entities party hereto, and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as administrative agent, issuing lender and swingline lender, dated as of April 25, 2024.

EXHBIT 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT This Third Amendment to Credit Agreement (this “Amendment”) dated and effective as of April 25, 2024 (the “Third Amendment Effective Date”) by and among ACCURAY INCORPORATED, a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto (the “Lenders”) and SILICON VALLEY BANK, a division of FIRST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORATED

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fil

Accuray Reports Fiscal 2024 Third Quarter Financial Results

Exhibit 99.1 Accuray Reports Fiscal 2024 Third Quarter Financial Results MADISON, Wis, May 1, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024. Third Quarter Fiscal 2024 Summary • Net revenue of $101.1 million decreased 14 percent from the same period in the prior fiscal year. Net revenue on a constant currency b

Q3’FY24 Earnings CallSupplemental Presentation May 1, 2024

Q3’FY24 Earnings Call Supplemental Presentation May 1, 2024 Forward-looking Statements This presentation is intended exclusively for investors.

ARAY / Accuray Incorporated / Archon Capital Management LLC Passive Investment

SC 13G/A 1 d1097228113g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Accuray Incorporated (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropr

ARAY / Accuray Incorporated / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv0174-accurayinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Accuray Inc Title of Class of Securities: Common Stock CUSIP Number: 004397105 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Sche

ARAY / Accuray Incorporated / Neuberger Berman Group LLC Passive Investment

SC 13G/A 1 formsc13ga-02122024080235.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* ACCURAY INC (Name of Issuer) Common (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORA

Accuray Reports Fiscal 2024 Second Quarter Financial Results 19% Order Growth YOY; 8% Service Revenue Expansion; Confirms FY24 Guidance

Exhibit 99.1 Accuray Reports Fiscal 2024 Second Quarter Financial Results 19% Order Growth YOY; 8% Service Revenue Expansion; Confirms FY24 Guidance MADISON, Wis, January 31, 2024 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter and six-months ended December 31, 2023. Second Quarter Fiscal 2024 Summary • Net revenue of $107.2 million increased 3 percent

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2024 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Q2’FY24 Earnings CallSupplemental Presentation January 31, 2024

Q2’FY24 Earnings Call Supplemental Presentation January 31, 2024 Forward-looking Statements This presentation is intended exclusively for investors.

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Accuray Incorporated (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value

As filed with the Securities and Exchange Commission on November 30, 2023

As filed with the Securities and Exchange Commission on November 30, 2023 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan and forms of award agreements thereunder

EXHIBIT 10.1 ACCURAY INCORPORATED AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN 1. Purposes of the Plan. The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to provide additional incentive to Employees, Directors and Consultants, and • to promote the success of the Company’s business. The Plan permits the grant of Inc

Q1’FY24 Earnings CallSupplemental Presentation November 7, 2023

Q1’FY24 Earnings Call Supplemental Presentation November 7, 2023 Forward-looking Statements This presentation is intended exclusively for investors.

Accuray Reports Fiscal 2024 First Quarter Financial Results Company Achieves 8% Revenue Growth, Reiterates FY 2024 Guidance

Exhibit 99.1 Accuray Reports Fiscal 2024 First Quarter Financial Results Company Achieves 8% Revenue Growth, Reiterates FY 2024 Guidance MADISON, Wis, November 7, 2023 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023. First Quarter Fiscal 2024 Summary • Net revenue of $103.9 million increased 7.7 percent from the s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPOR

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 07, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission Fil

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

Forward-looking Statements This presentation is intended exclusively for investors. 2 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are

Accuray Investor Briefing ASTRO 2023 Advancing Care, Creating Value San Diego, CA October 3, 2023 EXHIBIT 99.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by R

Amended and Restated Bylaws of Accuray Incorporated

EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF ACCURAY INCORPORATED (a Delaware corporation) (as of September 14, 2023) TABLE OF CONTENTS Article I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE. 1 1.2 OTHER OFFICES. 1 Article II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS. 1 2.2 ANNUAL MEETING. 1 2.3 SPECIAL MEETING. 1 2.4 ADVANCE NOTICE PROCEDURES; NOTICE OF STOCKHOLDERS’ MEETINGS. 1 2.5 MANNER OF G

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware 001-33301 20-8370041 (State or other jurisdiction of incorporation) (Commission

Third Amendment to Lease between Old Sauk Trails Park Limited Partnership and Accuray Incorporated, dated March 27, 2020.

Exhibit 10.4 1240 Deming Way Madison, Wisconsin THIRD AMENDMENT TO LEASE March 27, 2020 THIS AMENDMENT modifies a lease between Old Sauk Trails Park Limited Partnership as Landlord (“Landlord”) and Accuray Incorporated, as assignee from TomoTherapy Incorporated (“Tenant”) for the Premises at 1240 Deming Way, Madison, Wisconsin. RECITALS WHEREAS, Landlord and Tenant are parties to a Lease and Lease

Fourth Amendment to Lease Deming Way Property Group LLC and Accuray Incorporated, dated August 19, 2022.

Exhibit 10.5 FOURTH AMENDMENT TO LEASE THIS FOURTH AMENDMENT TO LEASE (this "Fourth Amendment") dated as of the 19th day of August 2022 (the "Effective Date") is between Deming Way Property Group LLC, a Wisconsin limited liability company ("Landlord"), and Accuray Incorporated, a Delaware corporation ("Tenant"). Recitals: WHEREAS, Landlord is the current landlord under the Lease (defined herein),

Office Lease between Old Sauk Trails Park Limited Partnership and TomoTherapy Incorporated, dated October 22, 2001.

Exhibit 10.1 OFFICE LEASE BETWEEN OLD SAUK TRAILS PARK LIMITED PARTNERSHIP LANDLORD AND TOMOTHERAPY INCORPORATED TENANT 1240 Deming Way Madison, Wisconsin 1240 Deming Way Madison, Wisconsin 53717 No. 6 REFERENCE DATA January 26, 2005 These terms are specific to, and incorporated in, this lease. ¶ no. Item Lease Provision 1.01 Tenant TomoTherapy Incorporated, a Wisconsin corporation 1.02 Premises A

Description of the Registrant’s Securities

EXHIBIT 4.7 DESCRIPTION OF CAPITAL STOCK General Our amended and restated certificate of incorporation authorizes us to issue up to 200,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of preferred stock, $0.001 par value per share. Common Stock Dividend Rights Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of

Second Amendment to Lease between Old Sauk Trails Park Limited Partnership and Accuray, Inc FKA TomoTherapy, Inc., dated October 19, 2016.

Exhibit 10.3 1240 Deming Way Madison, Wisconsin 53717 No. 8 REFERENCE DATA October 19, 2016 These terms are specific to, and incorporated in, this lease. No. Item Lease Provision 1.02 Premises Area of the Premises All of the building and seven below-grade test bunkers located outside of the building footprint 61,410 BOMA rentable square feet ("RSF'') excluding the seven below grade test located ou

List of subsidiaries.

Exhibit 21.1 Subsidiaries of the Registrant Name State or Jurisdiction of Organization Accuray International SARL Switzerland Accuray Europe SAS France Accuray UK, Ltd. United Kingdom Accuray Asia Ltd. Hong Kong Accuray Japan K.K. Japan Accuray Korea Limited Company Korea Accuray Spain, S.L.U. Spain Accuray Medical Equipment (India) Private Limited India Accuray Medical Equipment (Rus) LLC. Russia

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 A

First Amendment to Lease between Old Sauk Trails Park Limited Partnership and TomoTherapy Incorporated, dated May 1, 2004.

Exhibit 10.2 1240 Deming Way Madison, Wisconsin 53717 FIRST AMENDMENT TO LEASE The lease ("Lease") between Old Sauk Trails Park Limited Partnership ("Landlord") and TomoTherapy, Incorporated ("Tenant") for premises in the building located at 1240 Deming Way in the City of Madison, Dane County, Wisconsin, is amended as follows: 1 Section 1.02 is amended by deleting the last paragraph thereof, which

Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results 8% Q4 revenue growth; Record shipments for FY23; Company issues guidance for FY24

Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results 8% Q4 revenue growth; Record shipments for FY23; Company issues guidance for FY24 MADISON, Wisconsin, August 9, 2023— Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2023, ended June 30, 2023. Fourth Quarter Fiscal 2023 Summary • Net revenue of $118.3 million, an inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 09, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fi

Q4’FY23 Earnings Call August 9, 2023

Q4’FY23 Earnings Call August 9, 2023 Forward-looking Statements This presentation is intended exclusively for investors.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 ACCURAY INCORPORATED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Conflict Minerals Report of Accuray Incorporated

EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2022 TO DECEMBER 31, 2022 Background This Conflict Minerals Report (“Report”) of Accuray Incorporated (“Accuray”) for calendar year 2022 (the “Reporting Period”) has been prepared in accordance with Rule 13p-1 and Form SD under the Securities Exchange Act of 1934, as amended (together, the “Rule”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organi

SD 1 formsd2022.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.) 1310 Chesapeake Terrace Sunnyvale, Cali

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORATED

Executive Employment Agreement by and Between Registrant and Jesse Chew, dated January 1, 2023.

EXHIBIT 10.3 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2023 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Jesse Chew (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, including r

Consulting Agreement by and between Registrant and Franco Palomba, dated January 5, 2023.

EXHIBIT 10.5 Page 1 of NUMPAGES 1 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into by and between Franco Palomba (“CONSULTANT”) and Accuray Incorporated (“ACCURAY”), effective as of January 5, 2023 (“Effective Date”). W I T N E S S E T H WHEREAS, CONSULTANT voluntarily resigned from CONSULTANT’s employment with ACCURAY effective January 3, 2023; WHEREAS, C

Executive Employment Agreement by and between Registrant and Ali Pervaiz, dated January 1, 2023.

EXHIBIT 10.2 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2023 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Ali Pervaiz (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, including

Executive Employment Agreement by and Between Registrant and Suzanne Winter, dated January 1, 2023

EXHIBIT 10.1 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2023 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Suzanne Winter (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, includi

Executive Employment Agreement by and between Registrant and Michael Hoge, dated January 1, 2023.

EXHIBIT 10.4 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2023 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Michael Hoge (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, including

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fil

Q3’FY23 Earnings Call April 26, 2023

Q3’FY23 Earnings Call April 26, 2023 Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

Accuray Reports Fiscal 2023 Third Quarter Financial Results

Exhibit 99.1 Accuray Reports Fiscal 2023 Third Quarter Financial Results Company delivers record quarterly revenue and unit volume in Q3; Reiterates fiscal year guidance SUNNYVALE, Calif., April 26, 2023 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2023 ended March 31, 2023. Third Quarter Fiscal 2023 Summary • Net revenue of $118.1 million

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2023 ACCURAY INCORPORATED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 ACCURAY INCORPORATED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to th

2023 Cowen Healthcare Investor Conference Innovation Driven Growth Strategy March 6, 2023 Exhibit 99.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission File

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission

Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to th

Corporate Overview Innovation Driven Growth Strategy February 2023 Exhibit 99.1 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform

ARAY / Accuray Incorporated / Archon Capital Management LLC Passive Investment

SC 13G 1 d993149013g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Accuray Incorporated (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate b

ARAY / Accuray Incorporated / Neuberger Berman Group LLC - NONE Passive Investment

SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ACCURAY INC (Name of Issuer) Common (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi

First Amendment to Credit Agreement among Registrant, as the Borrower, the several banks and other financial institutions or entities party hereto, and Silicon Valley Bank, as administrative agent, issuing lender and swingline lender, dated as of October 28, 2022.

EX-10.1 2 aray-ex101.htm EX-10.1 EXHIBIT 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT This First Amendment to Credit Agreement (this “Amendment”) dated and effective as of October 28, 2022 (the “First Amendment Effective Date”) by and among ACCURAY INCORPORATED, a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto (the “Lenders”) and SILI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORA

Q2’FY23 Earnings Call February 1, 2023

Q2’FY23 Earnings Call February 1, 2023 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Accuray Reports Fiscal 2023 Second Quarter Financial Results

EX-99.1 2 aray-ex991.htm EX-99.1 Exhibit 99.1 Accuray Reports Fiscal 2023 Second Quarter Financial Results Delivered strong Q2 performance amidst challenging macroenvironment; Reiterate fiscal year guidance SUNNYVALE, Calif., February 1, 2023 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2023 ended December 31, 2022. Second Quarter Fiscal 2

Robert C. Kill Joins Accuray Board of Directors

EXHIBIT 99.3 Robert C. Kill Joins Accuray Board of Directors SUNNYVALE, Calif., February 1, 2023 – Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company’s Board of Directors, effective as of January 30, 2023. Mr. Kill is a skilled healthcare executive with more than 30 years’ experience transforming various healthcare-related companies. In his most re

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2023 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File N

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2022 ACCURAY INCORPOR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

As filed with the Securities and Exchange Commission on November 30, 2022

As filed with the Securities and Exchange Commission on November 30, 2022 Registration No.

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Accuray Incorporated (Exact name of registrant as specified in its charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value

Accuray Incorporated Form of Indemnification Agreement

EXHIBIT 10.1 ACCURAY INCORPORATED INDEMNIFICATION AGREEMENT This Indemnification Agreement (this ?Agreement?) is dated as of [insert date], and is between Accuray Incorporated, a Delaware corporation (the ?Company?), and [insert name of indemnitee] (?Indemnitee?). RECITALS A. Indemnitee?s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

Accuray Incorporated Amended and Restated 2007 Employee Stock Purchase Plan

EXHIBIT 10.2 EXHIBIT 10.2 AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN Accuray Incorporated hereby approves the Accuray Incorporated Amended and Restated 2007 Employee Stock Purchase Plan (the ?Plan?), effective as of the Effective Date (as defined herein). 1. Purpose. The purposes of the Plan are as follows: (a) To assist employees of the Company and its Designated Subsidiaries (as defi

Accuray Incorporated Amended and Restated 2006 Equity Incentive Plan and forms of award agreements thereunder

EXHIBIT 10.1 ACCURAY INCORPORATED AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN 1. Purposes of the Plan. The purposes of this Plan are: ? to attract and retain the best available personnel for positions of substantial responsibility, ? to provide additional incentive to Employees, Directors and Consultants, and ? to promote the success of the Company?s business. The Plan permits the grant of Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPOR

Consulting Agreement by and between Registrant and Brandy Green, effective September 2, 2022.

Exhibit 10.1 CONSULTING AGREEMENT This Consulting Agreement (this ?Agreement?) is made and entered into by and between Brandy Green (?CONSULTANT?) and Accuray Incorporated (?ACCURAY?), effective as of September 2, 2022 (?Effective Date?). W I T N E S S E T H WHEREAS, CONSULTANT voluntarily resigned from CONSULTANT?s employment with ACCURAY effective September 1, 2022; WHEREAS, CONSULTANT has train

Accuray Reports Fiscal 2023 First Quarter Financial Results

Exhibit 99.1 Accuray Reports Fiscal 2023 First Quarter Financial Results Strong customer demand. Navigating FX and Supply Chain Challenges. Company reiterates full year guidance. SUNNYVALE, Calif., November 2, 2022 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2023 ended September 30, 2022. First Quarter Fiscal 2023 Summary • Gross orders of

Q1’FY23 Earnings Call November 2, 2022

EX-99.2 3 aray-ex992.htm EX-99.2 Q1’FY23 Earnings Call November 2, 2022 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2022 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a?6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

DEF 14A 1 ny20004476x1def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A ? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.??) Filed by the Registrant ? ? ? Filed by a Party other than the Registrant ?? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Consulting Agreement by and between Registrant and Joshua H. Levine, dated July 1, 2022.

EX-10.47 7 aray-ex1047.htm EX-10.47 EXHIBIT 10.47 Page 1 of NUMPAGES 1 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into by and between Joshua H. Levine (“CONSULTANT”) and Accuray Incorporated (“ACCURAY”), effective as of July 1, 2022 (“Effective Date”). W I T N E S S E T H WHEREAS, CONSULTANT voluntarily resigned from CONSULTANT’s employment with ACCURAY a

Retention Package Letter by and between Registrant and Brandy Green, dated April 27, 2022.

EXHIBIT 10.44 April 27, 2022 Brandy Green Via e-mail Re: Retention Package Dear Brandy, Your contributions have been key to the success of Accuray Incorporated (the ?Company?). Accordingly, we are pleased to offer you a retention package in return for your continued service to the Company as an employee through September 1, 2022 (the ?Retention Period?) and transition assistance to Company managem

List of subsidiaries.

Exhibit 21.1 Subsidiaries of the Registrant Name State or Jurisdiction of Organization Accuray International SARL Switzerland Accuray Europe SAS France Accuray UK, Ltd. United Kingdom Accuray Asia Ltd. Hong Kong Accuray Japan K.K. Japan Accuray Spain, S.L.U. Spain Accuray Medical Equipment (India) Private Limited India Accuray Medical Equipment (Rus) LLC. Russia Accuray Medical Equipment GmbH Germ

Executive Employment Agreement by and between Registrant and Ali Pervaiz, dated May 9, 2022.

EX-10.45 5 aray-ex1045.htm EX-10.45 EXHIBIT 10.45 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (“Agreement”) is entered into and effective as of May 9, 2022 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Ali Pervaiz (“Executive”). RECITALS A. The Company is in the business of developing, manufacturing

Executive Employment Agreement by and between Registrant and Sandeep Chalke, dated May 2, 2022.

EXHIBIT 10.46 Page 1 of NUMPAGES 29 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (?Agreement?) is entered into and effective as of May 2, 2022 (?Effective Date?), by and between Accuray Incorporated, a Delaware corporation (the ?Company?), and Sandeep Chalke (?Executive?). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology,

Offer Letter by and between Registrant and Brandy Green, dated August 10, 2021.

EXHIBIT 10.43 August 10, 2021 Brandy Green via email Offer Letter Dear Brandy, Accuray Incorporated (the ?Company?) is pleased to extend this Offer Letter for you to assume the role of the Company?s Interim Chief Financial Officer in addition to your role as VP, Corporate Controller. The effective date of this interim role will be September 4, 2021 and during such time you will be reporting direct

Amended and Restated Executive Employment Agreement by and Between Registrant and Suzanne Winter, dated July 1, 2022.

EXHIBIT 10.41 Page 1 of NUMPAGES 30 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (?Agreement?) is entered into and effective as of July 1, 2022 (?Effective Date?), by and between Accuray Incorporated, a Delaware corporation (the ?Company?), and Suzanne Winter (?Executive?). RECITALS A. The Company is in the business of developing, manufacturing and sellin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 A

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission Fi

Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results 8.5% FY22 revenue growth; Company issues guidance for FY23

Exhibit 99.1 Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results 8.5% FY22 revenue growth; Company issues guidance for FY23 SUNNYVALE, Calif., August 10, 2022 ? Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2022 ended June 30, 2022. Q4 Fiscal 2022 and Recent Operating Highlights ? Gross orders of $88.3 million ? Net revenue of $

Q4’FY22 Earnings Call August 10, 2022

Q4?FY22 Earnings Call August 10, 2022 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the ?safe harbor? provisions of the Private Securities Litigation Reform Act of 1995.

Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

EXHIBIT 99.1 Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller SUNNYVALE, Calif., June 15, 2022 ? Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N. Palomba has joined the company as vice president, chief accounting officer & controller. Mr. Palomba will be responsible for the controllership function, including the global accounting organization and as

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

As filed with the Securities and Exchange Commission on May 31, 2022

As filed with the Securities and Exchange Commission on May 31, 2022 Registration No.

Filing Fee Table

EX-FILING FEES 6 d353142dexfilingfees.htm EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Accuray Incorporated (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) (2) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price Fee

Form of Accuray Incorporated Stand-Alone Inducement Stock Option Agreement.

EXHIBIT 99.2 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT STOCK OPTION AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Option. Otherwise, Participant will be deemed to have accepted the Option on the terms and conditions on which it is offered. NOTICE OF STOCK OPTION GRANT Participant Name: Sandeep

Form of Accuray Incorporated Stand-Alone Inducement Restricted Stock Unit Agreement.

EXHIBIT 99.1 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT RESTRICTED STOCK UNIT AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Award. Otherwise, Participant will be deemed to have accepted the Award on the terms and conditions on which it is offered. NOTICE OF GRANT OF RESTRICTED STOCK UNIT AWARD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.) 1310 Chesapeake Terrace Sunnyvale, California 94089 (Address o

Conflict Minerals Report of Accuray Incorporated

EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2021 TO DECEMBER 31, 2021 Background This Conflict Minerals Report (?Report?) of Accuray Incorporated (?Accuray?) for calendar year 2021 (the ?Reporting Period?) has been prepared in accordance with Rule 13p-1 and Form SD under the Securities Exchange Act of 1934, as amended (together, the ?Rule?

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORATED

Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member Accuray Also Announces Chief Financial Officer, Ali Pervaiz

Exhibit 99.2 Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member Accuray Also Announces Chief Financial Officer, Ali Pervaiz SUNNYVALE, Calif., April 27, 2022 ? Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter, President, will succeed Joshua Levine as the company?s Chief Executive Officer, effective Ju

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2022 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to th

Q3?FY22 Earnings Call April 27, 2022 Exhibit 99.3 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the ?safe harbor? provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking

Accuray Reports Fiscal 2022 Third Quarter Financial Results

Exhibit 99.1 Accuray Reports Fiscal 2022 Third Quarter Financial Results SUNNYVALE, Calif., April 27, 2022 ? Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2022 ended March 31, 2022. Third Quarter Fiscal 2022 Summary ? Gross orders of $88.6 million, an increase of 1 percent compared to the prior year ? Net revenue of $96.2 million representing

ARAY / Accuray Incorporated / Neuberger Berman Group LLC - NONE Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* ACCURAY INC (Name of Issuer) Common (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORA

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2022 ACCURAY INCORPORATED (Exact name of Registrant as Specified in Its Charter) Delaware 001-33301 20-8370041 (State or Other Jurisdiction of Incorporation) (Commission F

Q2’FY22 Earnings Call January 26, 2022

Q2?FY22 Earnings Call January 26, 2022 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the ?safe harbor? provisions of the Private Securities Litigation Reform Act of 1995.

Accuray Reports Fiscal 2022 Second Quarter Financial Results Record Revenue For Second Quarter Fiscal 2022

Exhibit 99.1 Accuray Reports Fiscal 2022 Second Quarter Financial Results Record Revenue For Second Quarter Fiscal 2022 SUNNYVALE, Calif., January 26, 2022 ? Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2022 ended December 31, 2021. Second Quarter Fiscal 2022 Summary ? Record net revenue of $116.3 million representing an increase of 19 perce

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPOR

Accuray Reports Fiscal 2022 First Quarter Financial Results Record Revenue First Quarter Fiscal 2022

Exhibit 99.1 Joseph Diaz Beth Kaplan Managing Partner, Investor Relations, Lytham Partners, LLC Public Relations Director, Accuray +1 (602) 889-9660 +1 (408) 789-4426 [email protected] [email protected] Accuray Reports Fiscal 2022 First Quarter Financial Results Record Revenue First Quarter Fiscal 2022 SUNNYVALE, Calif., November 3, 2021 ? Accuray Incorporated (NASDAQ: ARAY) today reported finan

Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to th

Q1?FY22 Earnings Call November 3, 2021 Exhibit 99.2 Proprietary and Confidential Property of Accuray Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the ?safe harbor? provisions of the Private Securities Litigation Reform Act of 1995. Forward-lookin

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Accuray Transforming Patient Care Through Innovation Investor Day October 25, 2021

1 Proprietary and Confidential Property of Accuray Accuray Overview Video Exhibit 99.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million

Exhibit 99.1 Joe Diaz Beth Kaplan Investor Relations, Lytham Partners Public Relations Director, Accuray +1 (602) 717-7804 +1 (408) 789-4426 [email protected] [email protected] Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million SUNNYVALE, Calif., October 21, 2021 ? Accuray Incorporated (NASDAQ:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.??) Filed by the Registrant ? ? ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? ? ? Preliminary Proxy Statement ?? ? ? Confidential, for Use of the Commission Only (as perm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a?6(e)(2)) ? Defin

Mika Nishimura Joins Accuray Board of Directors

EXHIBIT 99.1 Mika Nishimura Joins Accuray Board of Directors SUNNYVALE, Calif., August 23, 2021 ? Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company?s Board of Directors, effective as of August 17, 2021. With Ms. Nishimura?s appointment, the Accuray Board will consist of nine members. Ms. Nishimura also currently serves as an Independent Director o

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File N

Credit Agreement among the Registrant, as the Borrower, the several lenders from time to time party thereto, and Silicon Valley Bank, as administrative agent, lead arranger, issuing lender and swingline lender, dated as of May 6, 2021.

Exhibit 10.56 SENIOR SECURED CREDIT FACILITIES CREDIT AGREEMENT dated as of May 6, 2021, among ACCURAY INCORPORATED, as the Borrower, The Several Lenders from Time to Time PartY Hereto, and SILICON VALLEY BANK, as Administrative Agent, Lead Arranger, Issuing Lender and Swingline Lender Table of Contents Page SECTION 1 DEFINITIONS 1 1.1 Defined Terms 1 1.2 Other Definitional Provisions. 46 1.3 Roun

List of subsidiaries.

Exhibit 21.1 Subsidiaries of the Registrant Name State or Jurisdiction of Organization Accuray International SARL Switzerland Accuray Europe SAS France Accuray UK, Ltd. United Kingdom Accuray Asia Ltd. Hong Kong Accuray Japan K.K. Japan Accuray Spain, S.L.U. Spain Accuray Medical Equipment (India) Private Limited India Accuray Medical Equipment (Rus) LLC. Russia Accuray Medical Equipment GmbH Germ

Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan and forms of award agreements thereunder.

Exhibit 10.15 ACCURAY INCORPORATED AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: ?to attract and retain the best available personnel for positions of substantial responsibility, ?to provide additional incentive to Employees, Directors and Consultants, and ?to promote the success of the Company?s business. The Plan permits the grant of Incent

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 ACCURAY INCORPORATE

Amended and Restated Executive Employment Agreement by and Between Registrant and Suzanne Winter, dated July 1, 2021.

Exhibit 10.39 Page 1 of 30 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (?Agreement?) is entered into and effective as of July 1, 2021 (?Effective Date?), by and between Accuray Incorporated, a Delaware corporation (the ?Company?), and Suzanne Winter (?Executive?). RECITALS A.The Company is in the business of developing, manufacturing and selling radiatio

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Q4’FY21 Earnings Call Fiscal Year End 2021 August 11, 2021

Q4?FY21 Earnings Call Fiscal Year End 2021 August 11, 2021 Proprietary and Confidential Property of Accuray FORWARD-LOOKING STATEMENTS This presentation is intended exclusively for investors.

Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results

Exhibit 99.1 Joe Diaz Beth Kaplan Investor Relations, Lytham Partners Public Relations Director, Accuray +1 (602) 717-7804 +1 (408) 789-4426 [email protected] [email protected] Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results SUNNYVALE, Calif., August 11, 2021 ? Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Accuray Announces Promotion of Suzanne Winter to President

EXHIBIT 99.1 Accuray Announces Promotion of Suzanne Winter to President SUNNYVALE, Calif., June 22, 2021 ? Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021. Ms. Winter, who previously served as the company?s chief commercial officer and senior vice president of R&D and medical and scientific affairs, brings more than 25 years o

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Conflict Minerals Report of Accuray Incorporated

EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ACCURAY INCORPORATED FOR THE REPORTING PERIOD FROM JANUARY 1, 2020 TO DECEMBER 31, 2020 Background This Conflict Minerals Report (“Report”) of Accuray Incorporated (“Accuray”) for calendar year 2020 (the “Reporting Period”) has been prepared in accordance with Rule 13p-1 and Form SD under the Securities Exchange Act of 1934, as amended (together, the “Rule”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.) 1310 Chesapeake Terrace Sunnyvale, California 94089 (Address o

Indenture, dated as of May 13, 2021, between the Registrant and The Bank of New York Mellon Trust Company, N.A., as trustee

EX-4.1 2 d131245dex41.htm EX-4.1 Exhibit 4.1 ACCURAY INCORPORATED and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee INDENTURE Dated as of May 13, 2021 3.75% CONVERTIBLE SENIOR NOTES DUE 2026 TABLE OF CONTENTS Page I. DEFINITIONS AND INCORPORATION BY REFERENCE 1.01 Definitions 1 1.02 Other Definitions 9 1.03 Incorporation by Reference of Trust Indenture Act 10 1.04 Rules of Constructio

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Numb

Accuray Announces Convertible Notes Exchange and Subscription

Exhibit 99.1 Accuray Announces Convertible Notes Exchange and Subscription SUNNYVALE, Calif., May 6, 2021 ? Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2022 (the ?2022 Notes?) to exchange an aggregate of $82.1 million principal amount of 2022 Notes for approximately

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Numbe

Form of Subscription Agreement, dated as of May 6, 2021, between the Registrant and each signatory thereto

EX-10.2 3 d379669dex102.htm EX-10.2 Exhibit 10.2 Accuray Incorporated % Convertible Notes due 2026 SUBSCRIPTION AGREEMENT (the “Subscription Agreement”) Dated as of May [•], 2021 The undersigned (the “Purchaser”) hereby confirms its agreement with you as follows: This Subscription Agreement and the Terms and Conditions for the Subscription of Securities, dated May [•], 2021, attached hereto as Exh

Form of Exchange Agreement, dated as of May 6, 2021, between the Registrant and each signatory thereto.

EX-10.1 2 d379669dex101.htm EX-10.1 Exhibit 10.1 Accuray Incorporated % Convertible Notes due 2026 FORM OF EXCHANGE AGREEMENT Dated as of May [•], 2021 The undersigned (the “Holder”), for itself and on behalf of the beneficial owners listed on Exhibit B.1 hereto (“Accounts”) for whom the Holder holds contractual and investment authority (each, including the Holder if it is the party exchanging Old

Accuray Announces New $120 Million Credit Facility Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility

Exhibit 99.2 Accuray Announces New $120 Million Credit Facility Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility SUNNYVALE, Calif., May 6, 2021 ? Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facility with Silicon Valley Bank and a syndicate of

Form of Accuray Incorporated Stand-Alone Inducement Restricted Stock Unit Agreement for J.P. Pignol

EX-99.1 4 aray-ex9919.htm EX-99.1 Exhibit 99.1 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT RESTRICTED STOCK UNIT AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Award. Otherwise, Participant will be deemed to have accepted the Award on the terms and conditions on which it is offered. NOTICE OF GRA

- S-8

As filed with the Securities and Exchange Commission on April 30, 2021 Registration No.

Form of Accuray Incorporated Stand-Alone Inducement Stock Option Agreement for J.P. Pignol

Exhibit 99.2 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT STOCK OPTION AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Option. Otherwise, Participant will be deemed to have accepted the Option on the terms and conditions on which it is offered. NOTICE OF STOCK OPTION GRANT Participant Name:Jean-Phi

Executive Employment Agreement by and between Registrant and Michael Hoge, dated January 1, 2021

EXHIBIT 10.5 Page 1 of 30 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (?Agreement?) is entered into and effective as of January 1, 2021 (?Effective Date?), by and between Accuray Incorporated, a Delaware corporation (the ?Company?), and Michael Hoge (?Executive?). RECITALS A. The Company is in the business of developing, manufacturing and selling radiation oncology, includin

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORATED

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Accuray Reports Third Quarter Fiscal 2021 Financial Results

EX-99.1 2 aray-ex9916.htm EX-99.1 Exhibit 99.1 Joe Diaz Beth Kaplan Investor Relations, Lytham Partners Public Relations Director, Accuray +1 (602) 717-7804 +1 (408) 789-4426 [email protected] [email protected] Accuray Reports Third Quarter Fiscal 2021 Financial Results SUNNYVALE, Calif., April 27, 2021 — Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quar

Accuray Reports Third Quarter Fiscal 2021 Financial Results

Exhibit 99.1 Joe Diaz Beth Kaplan Investor Relations, Lytham Partners Public Relations Director, Accuray +1 (602) 889-9700 +1 (408) 789-4426 [email protected] [email protected] Accuray Reports Third Quarter Fiscal 2021 Financial Results SUNNYVALE, Calif., April 27, 2021 ? Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2021 ended Mar

Financial Statements and Exhibits, Results of Operations and Financial Condition

? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File

Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors

EX-99.1 2 aray-ex9916.htm EX-99.1 EXHIBIT 99.1 Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors SUNNYVALE, Calif., February 19, 2021 – Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company’s Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant experience as a physician e

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* ACCURAY INC (Name of Issuer) (Title of Class of Securities) (CUSIP Number) December 31, 2020 (Date of E

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* ACCURAY INC (Name of Issuer) Common (Title of Class of Securities) 004397105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Accuray Inc Title of Class of Securities: Common Stock CUSIP Number: 004397105 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13

Executive Employment Agreement by and between Registrant and Suzanne Winter, dated January 1, 2021.

EX-10.2 3 aray-ex10229.htm EXHIBIT 10.2 - WINTER, SUZANNE 2021 EMPLOYMENT AGMT STD. 11.10.20, 12.15.20 CLEAN Exhibit 10.2 Page 1 of 30 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2021 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Suzanne Winter (“Executive”). R

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPORA

Executive Employment Agreement by and between Registrant and Shigeyuki Hamamatsu, dated January 1, 2021

Exhibit 10.1 Page 1 of 30 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2021 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Shig Hamamatsu (“Executive”). RECITALS A.The Company is in the business of developing, manufacturing and selling radiation oncology, includi

Executive Employment Agreement by and Between Registrant and Patrick Spine, dated January 1, 2021

EX-10.3 4 aray-ex10328.htm EXHIBIT 10.3 - SPINE, PATRICK, 2021 EMPLOYMENT AGMT STD. 11.10.20, 12.15.20 CLEAN Exhibit 10.3 Page 1 of 29 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2021 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Patrick Spine (“Executive”). RE

Executive Employment Agreement by and between Registrant and Jesse Chew, dated January 1, 2021.

Exhibit 10.4 Page 1 of 30 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (“Agreement”) is entered into and effective as of January 1, 2021 (“Effective Date”), by and between Accuray Incorporated, a Delaware corporation (the “Company”), and Jesse Chew (“Executive”). RECITALS A.The Company is in the business of developing, manufacturing and selling radiation oncology, including r

Accuray Reports Second Quarter Fiscal 2021 Financial Results

EX-99.1 2 aray-ex9916.htm EX-99.1 Exhibit 99.1 Joe Diaz Beth Kaplan Investor Relations, Lytham Partners Public Relations Director, Accuray +1 (602) 889-9700 +1 (408) 789-4426 [email protected] [email protected] Accuray Reports Second Quarter Fiscal 2021 Financial Results SUNNYVALE, Calif., January 27, 2021 — Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the s

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securit

Accuray Innovation Driven Growth Strategy 2021 J.P. Morgan Healthcare Conference January 14, 2021 Exhibit 99.1 Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forw

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2021 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Form of Accuray Incorporated Stand-Alone Inducement Restricted Stock Unit Agreement for Jim Dennison

EXHIBIT 99.4 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT RESTRICTED STOCK UNIT AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Award. Otherwise, Participant will be deemed to have accepted the Award on the terms and conditions on which it is offered. NOTICE OF GRANT OF RESTRICTED STOCK UNIT AWARD

Form of Accuray Incorporated Stand-Alone Inducement Stock Option Agreement for Jim Dennison

EXHIBIT 99.5 ACCURAY INCORPORATED STAND-ALONE INDUCEMENT STOCK OPTION AGREEMENT Participant must notify the Company by the fifteenth (15th) day of the month following the Date of Grant if he or she wishes to reject this Option. Otherwise, Participant will be deemed to have accepted the Option on the terms and conditions on which it is offered. NOTICE OF STOCK OPTION GRANT Participant Name:Jim Denn

- S-8

As filed with the Securities and Exchange Commission on November 30, 2020 Registration No.

Amended and Restated 2007 Employee Stock Purchase Plan.

EXHIBIT 10.2 AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN Accuray Incorporated hereby approves the Accuray Incorporated Amended and Restated 2007 Employee Stock Purchase Plan (the “Plan”), effective as of the Effective Date (as defined herein). 1. Purpose. The purposes of the Plan are as follows: (a)To assist employees of the Company and its Designated Subsidiaries (as defined below) in

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2020 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.

Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan

EXHIBIT 10.1 ACCURAY INCORPORATED AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN 1.Purposes of the Plan. The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to provide additional incentive to Employees, Directors and Consultants, and • to promote the success of the Company’s business. The Plan permits the grant of Ince

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33301 ACCURAY INCORPOR

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2020 ACCURAY INCORPORATED (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-33301 20-8370041 (Commission File Number) (IRS Employer Identification No.